合并2型糖尿病的乳腺癌患者临床特点及预后分析  

Analysis of Clinical Features and Prognosis of Patients with Breast Cancer and Type 2 Diabetes

作　　者：孙亚华[1] 徐红双[1] 张延勇[1] 

机构地区：[1]齐齐哈尔医学院附属第三医院内分泌二科,黑龙江齐齐哈尔161000

出　　处：《糖尿病新世界》2017年第2期58-59,共2页Diabetes New World Magazine

摘　　要：目的分析乳腺癌合并2型糖尿病患者的临床特点与预后。方法随机选择于2014年10月—2015年10月间该院收治的乳腺癌合并2型糖尿病患者61例,将其纳入研究组,而后选择同期到该院进行救治的非糖尿病乳腺癌患者122例,将其纳入常规组,回顾性分析两组患者临床资料。结果比较常规组,研究组患者体质量、年龄以及绝境后患者占比最大,组间数据对比差异有统计学意义(P<0.05),研究组患者的肿瘤分期晚于常规组,且原发肿瘤直径大于常规组,腋窝淋巴结阳性率高于常规组,差异有统计学意义(P<0.05)。研究组复发转移率高于常规组(P<0.05)。结论乳腺癌合并2型糖尿病患者,预后较差,具有较高的复发转移率,导致预后较差的原因或许在于合并2型糖尿病,基于此,术后医护人员应当高度重视随访。Objective To analyze the clinical features and prognosis of patients with breast cancer and type 2 diabetes.Methods 61 cases of patients with breast cancer and type 2 diabetes admitted and treated in our hospital from October2014 to October 2015 were randomly selected as the research group, 122 cases of patients without breast cancer or type 2diabetes treated in our hospital at the same period were selected as the routine group, and the clinical data were reviewed and analyzed. Results The body weight, age and ratio patients after impasse was higher than those in the routine group, and the differences were obvious with statistical significance(P <0.05), and the tumor staging in the research group was later than that in the routine group, and the primary tumor diameter was bigger than that in the routine group, and the positive rate of axillary nodes was higher than that in the routine group with statistical significance(P<0.05), and the recurrence and metastasis rate in the research group was higher than that in the routine group(P <0.05). Conclusion The prognosis of patients with breast cancer and type 2 diabetes is worse with higher recurrence and metastasis rate, which may be caused by the type 2 diabetes, therefore, the medical staff should attach highly importance to the follow-up after operation.

关 键 词：2型糖尿病 乳腺癌 临床特点 预后 

分 类 号：R587.1[医药卫生—内分泌]